The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Lipoprotein Subfraction Changes in Normal Pregnancy: Threshold Effect of Plasma Triglyceride on Appearance of Small, Dense Low Density Lipoprotein1
Abstract
A detailed longitudinal examination of plasma lipoprotein subfraction concentrations and compositions in pregnancy was performed with the objective of discovering the pattern of change in lipoprotein subfractions. Plasma triglyceride, cholesterol, very low density lipoprotein (VLDL1), very low density lipoprotein (VLDL2), intermediate density lipoprotein (IDL), low density lipoprotein (LDL) and its subfractions (LDL-I, LDL-II, LDL-III), and high density lipoprotein-cholesterol (HDL cholesterol) were quantified in 10 normal pregnant women from 10 weeks of gestation and at 5 weekly intervals thereafter, until 35 weeks of gestation, together with circulating hepatic lipase (at 10 and 35 weeks) and serum estradiol concentration. Median concentrations of VLDL1 (19-109 mg/dL), VLDL2 (17-103 mg/dL) and IDL (26-124 mg/dL) increased in parallel (maximum increase around 5-fold) as plasma triglyceride increased with advancing gestation. This contrasts with observations in the normal non-pregnant female, where higher concentrations of plasma triglyceride are associated with preferentially higher VLDL1 concentrations. The rise in IDL was also remarkable as this does not normally accompany changes in plasma triglyceride. LDL mass increased by 70% (200-353 mg/dL) between 10 and 35 weeks, and in 6 of the 10 women studied, the LDL subfraction pattern was modified towards a smaller denser pattern in a manner suggestive of a "threshold" transition, with the proportion of LDL-III increasing at the expense of LDL-II, whereas in the other 4 women, LDL subfraction profile remained unchanged throughout pregnancy. Interestingly, this "threshold" transition, if it occurred, did so at varying gestational ages and triglyceride concentrations for different women. The likelihood of LDL subfraction change and the final concentration of small, dense. LDL-III were related to the 10-week triglyceride concentration (R2 = 36.7%, P = 0.063) and to the rate of change in triglyceride for a given increment in estrogen (R2 = 48.6%, P = 0.025). In addition, VLDL1 mass exceeded 100 mg/dL during pregnancy only in those individuals in whom LDL profile perturbation was evident (chi 2, P < 0.001). LDL profile change was evident at the lowest triglyceride concentrations in the 2 individuals with the highest increments in triglyceride corrected for estrogen. On the basis of these longitudinal observations, we conclude the following: 1) as plasma triglyceride increases in pregnancy, there are parallel rises in median concentrations of VLDL1, VLDL2 and IDL, around 5-fold; 2) as a result of this progressive increase in plasma triglyceride, in particular in VLDL1, the LDL profile is altered in some individuals towards smaller, dense particles; 3) in general, the higher the initial (booking) fasting plasma triglyceride concentration or the larger the rate of change in triglyceride for a given increment in estradiol, the greater the probability of change in LDL profile towards smaller denser species; 4) significantly, LDL subclass perturbation towards smaller denser species occurs not in a gradual and progressive manner but exhibits "threshold" behavior; and finally, 5) this threshold is achieved at differing gestational ages and triglyceride concentrations for different women.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk
Austin, M. A., King, M. C., Vranizan, K. M., & Krauss, R. M. (1990) · Circulation · doi:10.1161/01.cir.82.2.495 · Cited by 1,411
Walsh, B. W., Schiff, I., Rosner, B., Greenberg, L., Ravnikar, V., & Sacks, F. M. (1991) · New England Journal of Medicine · doi:10.1056/nejm199110243251702 · Cited by 1,152
Gardner, C. D. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540110029028 · Cited by 843 · cited 1×
“Furthermore, recently reported prospective studies have demonstrated that the presence of small, dense LDL particles precedes CHD (15, 16 ) and predicts the development of noninsulin dependent diabetes mellitus (17).”
BackgroundGriffin, B. A., Freeman, D. J., Tait, G. W., Thomson, J., Caslake, M. J., Packard, C. J., & Shepherd, J. (1994) · Atherosclerosis · doi:10.1016/0021-9150(94)90129-5 · Cited by 525
Self-citationMcNamara, J. R., Small, D. M., Li, Z., & Schaefer, E. J. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37557-x · Cited by 147
Austin, M. A., & Edwards, K. L. (1996) · Current Opinion in Lipidology · doi:10.1097/00041433-199606000-00010 · Cited by 126 · cited 1×
“In men and in nonpregnant women, plasma triglyceride is the major determinant of small dense LDL, accounting for 40 ‐ 60% of the variability of this fraction in the plasma (12, 14, 18 , 19).”
BackgroundEffects of simvastatin on apoB metabolism and LDL subfraction distribution
Gaw, A., Packard, C. J., Murray, E. F., Lindsay, G. M., Griffin, B. A., Caslake, M. J., Vallance, B. D., Lorimer, A. R., & Shepherd, J. (1993) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.13.2.170 · Cited by 104
Self-citationWARTH, M. R., ARKY, R. A., & KNOPP, R. H. (1975) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-41-4-649 · Cited by 100
Cited by
Maternal Obesity Is Associated with Dysregulation of Metabolic, Vascular, and Inflammatory Pathways
Ramsay, J. E., Ferrell, W. R., Crawford, L., Wallace, A. M., Greer, I. A., & Sattar, N. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020311 · Cited by 659
Self-citationRecent Insights into the Pathogenesis of Pre-eclampsia
Roberts, J. M., & Lain, K. Y. (2002) · Placenta · doi:10.1053/plac.2002.0819 · Cited by 597
Gilbert, J. S., Ryan, M. J., LaMarca, B. B., Sedeek, M., Murphy, S. R., & Granger, J. P. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01113.2007 · Cited by 558
Intermediate metabolism in normal pregnancy and in gestational diabetes
Di Cianni, G., Miccoli, R., Volpe, L., Lencioni, C., & Del Prato, S. (2003) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.390 · Cited by 406
Granger, J. P., Alexander, B. T., Llinas, M. T., Bennett, W. A., & Khalil, R. A. (2001) · Hypertension · doi:10.1161/01.hyp.38.3.718 · Cited by 401
Activated Protein C Sensitivity, Protein C, Protein S and Coagulation in Normal Pregnancy
Brennand, J., Conkie, J. A., McCall, F., Greer, I. A., Walker, I., & Clark, P. (1998) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1615035 · Cited by 386
Self-citationMagnussen, E. B., Vatten, L. J., Lund-Nilsen, T. I., Salvesen, K. Å., Smith, G. D., & Romundstad, P. R. (2007) · BMJ · doi:10.1136/bmj.39366.416817.be · Cited by 370
Maternal metabolism and obesity: modifiable determinants of pregnancy outcome
Nelson, S. M., Matthews, P., & Poston, L. (2010) · Human Reproduction Update · doi:10.1093/humupd/dmp050 · Cited by 370
Sniderman, A. D., Scantlebury, T., & Cianflone, K. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-6-200109180-00014 · Cited by 336
Vrijkotte, T. G. M., Krukziener, N., Hutten, B. A., Vollebregt, K. C., van Eijsden, M., & Twickler, M. B. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1295 · Cited by 312
Oxidative stress and normal pregnancy
Toescu, V., Nuttall, S. L., Martin, U., Kendall, M. J., & Dunne, F. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01638.x · Cited by 280
Wiznitzer, A., Mayer, A., Novack, V., Sheiner, E., Gilutz, H., Malhotra, A., & Novack, L. (2009) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2009.05.032 · Cited by 276
Pre-eclampsia and cardiovascular disease: metabolic syndrome of pregnancy?
RODIE, V (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.01.038 · Cited by 275
Maternal triglyceride levels and newborn weight in pregnant women with normal glucose tolerance
Di Cianni, G., Miccoli, R., Volpe, L., Lencioni, C., Ghio, A., Giovannitti, M. G., Cuccuru, I., Pellegrini, G., Chatzianagnostou, K., Boldrini, A., et al. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01336.x · Cited by 257
Causes and consequences of hypertriglyceridemia
Packard, C. J., Boren, J., & Taskinen, M.-R. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00252 · Cited by 239
Self-citationMaternal adiposity—a determinant of perinatal and offspring outcomes?
Lawlor, D. A., Relton, C., Sattar, N., & Nelson, S. M. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.176 · Cited by 192
Self-citationGriffith, R. J., Alsweiler, J., Moore, A. E., Brown, S., Middleton, P., Shepherd, E., & Crowther, C. A. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012394.pub3 · Cited by 149
Recent Progress Toward the Understanding of the Pathophysiology of Hypertension During Preeclampsia
LaMarca, B. D., Gilbert, J., & Granger, J. P. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.108837 · Cited by 142
Cord blood lipoproteins and prenatal influences
Bansal, N., Cruickshank, J. K., McElduff, P., & Durrington, P. N. (2005) · Current Opinion in Lipidology · doi:10.1097/01.mol.0000174154.61307.16 · Cited by 98
Castelao, J. E., & Gago-Dominguez, M. (2008) · Medical Hypotheses · doi:10.1016/j.mehy.2007.10.016 · Cited by 79
Pecks, U., Rath, W., Kleine-Eggebrecht, N., Maass, N., Voigt, F., Goecke, T., Mohaupt, M., & Escher, G. (2016) · Geburtshilfe und Frauenheilkunde · doi:10.1055/s-0042-107078 · Cited by 53
“The importance of lipid [8,22] and steroid hormone metabolism [23,24] for the maintenance of pregnancy has long been known.”
Background
Metadata
- Authors
- Sattar, N., Greer, I. A., Louden, J., Lindsay, G., McConnell, M., Shepherd, J., & Packard, C. J.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1997-08
- Volume
- 82
- Issue
- 8
- Pages
- 2483-2491
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2158103028
- Cited by
- 189
- References
- 8
- FWCI
- 3.25
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.